Recombinant human epidermal growth factor
Term · Oncology and biomedicine · MLC-T-ONC-016416
A recombinant form of the naturally-occurring polypeptide human epidermal growth factor with potential epithelial regenerative and cytoprotective activities. Upon topical application, recombinant human epidermal growth factor (rhEGF) may stimulate epithelial proliferation, differentiation and migration, which may result in the acceleration of epithelial regeneration and wound healing. In addition, rhEGF may attenuate epithelial cytotoxicities related to chemotherapy and/or radiotherapy.
| Identifier | MLC-T-ONC-016416 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rhEGF |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016416",
"term": "Recombinant human epidermal growth factor",
"field": "Oncology and biomedicine",
"definition": "A recombinant form of the naturally-occurring polypeptide human epidermal growth factor with potential epithelial regenerative and cytoprotective activities. Upon topical application, recombinant human epidermal growth factor (rhEGF) may stimulate epithelial proliferation, differentiation and migration, which may result in the acceleration of epithelial regeneration and wound healing. In addition, rhEGF may attenuate epithelial cytotoxicities related to chemotherapy and/or radiotherapy.",
"abbreviation": "rhEGF",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-human-epidermal-growth-factor/"
}
Record 14,155 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.